New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 6, 2014
07:14 EDTHRTXHeron Therapeutics price target raised to $20 from $16 at JMP Securities
JMP Securities increased its price target on Heron after the company reported higher than expected EPS and stated that its new post-surgical pain program is expected to have its first clinical data later this year. The firm recommends owning the stock ahead of what it believes will be upcoming catalysts.
News For HRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 15, 2015
07:28 EDTHRTXHeron Therapeutics shares remain undervalued, says Brean Capital
Subscribe for More Information
May 14, 2015
08:01 EDTHRTXHeron Therapeutics says FDA accepts propsal to use 505(b)(2) pathway for HTX-019
Subscribe for More Information
May 8, 2015
08:07 EDTHRTXHeron Therapeutics reports Q1 EPS (70c), consensus (68c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use